Blau Farmaceutica (BSP:BLAU3) Total Stockholders Equity : R$2,202 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Blau Farmaceutica Total Stockholders Equity?

Blau Farmaceutica's Total Stockholders Equity for the quarter that ended in Mar. 2025 was R$2,202 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Blau Farmaceutica's Book Value per Share for the quarter that ended in Mar. 2025 was R$12.39. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Blau Farmaceutica's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.25.

Blau Farmaceutica Total Stockholders Equity Historical Data

The historical data trend for Blau Farmaceutica's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blau Farmaceutica Total Stockholders Equity Chart

Blau Farmaceutica Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

221.34

1,636.29

1,822.16

2,001.46

2,163.99

Blau Farmaceutica Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															2,019.48	2,042.72	2,097.21	2,163.99	2,201.56

Blau Farmaceutica (BSP:BLAU3) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Blau Farmaceutica's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2201.563	-	0)	/	177.681
	=	12.39

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Blau Farmaceutica's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(66.444	+	484.99)	/	2201.563
	=	0.25

Blau Farmaceutica Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Blau Farmaceutica's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Blau Farmaceutica Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blau Farmaceutica SA (BSP:BLAU3) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rodovia Raposo Tavares, No. 2833, Km 30.5, Barro Branco, Cotia, SP, BRA, 06705-030

Website

https://www.blau.com

Blau Farmaceutica SA is engaged in the manufacturing, development and commercialization of complex private-label drugs for the institutional segment. The Company's business activities cover institutional and retail segments, and are divided into four units: 1) Biologicals are a heterogeneous class of products that can be produced using raw materials from biological materials and biotechnological procedures. 2) Oncology line is made up of oral and injectable drugs intended for treating cancer, which encompasses a number of therapeutic classes. 3) Specialties line is made up of products that are used in the hospital's daily routine, in the specialized treatments for infectious diseases and special treatments. 4) Others consist of prescription and non-prescription over-the-counter drugs.

Blau Farmaceutica Headlines

No Headlines